The prognostic value of endogenous hypoxia-related markers for head and neck squamous cell carcinomas treated with ARCON

This publication has 35 references indexed in Scilit:

• Comparison of different methods of CAIX quantification in relation to hypoxia in three human head and neck tumor lines
  Radiotherapy and Oncology, 2005
• Does heterogeneity of pimonidazole labelling correspond to the heterogeneity of radiation-response of FaDu human squamous cell carcinoma?
  Radiotherapy and Oncology, 2005
• Microregional Expression of Glucose Transporter-1 and Oxygenation Status: Lack of Correlation in Locally Advanced Cervical Cancers
  Clinical Cancer Research, 2005
• Utility of 19F MRS detection of the hypoxic cell marker EF5 to assess cellular hypoxia in solid tumors
  Radiotherapy and Oncology, 2004
• Overexpression of Glut‐1 and increased glucose metabolism in tumors are associated with a poor prognosis in patients with oral squamous cell carcinoma
  Cancer, 2003
• GLUT‐1 and CAIX as intrinsic markers of hypoxia in carcinoma of the cervix: Relationship to pimonidazole binding
  International Journal of Cancer, 2003
• Clinical Significance of Glucose Transporter 1 (GLUT1) Expression in Human Breast Carcinoma
  Japanese Journal of Cancer Research, 2002
• Glut3 Expression in Biopsy Specimens of Laryngeal Carcinoma Is Associated With Poor Survival
  The Laryngoscope, 2002
• Regulation of glucose transport by hypoxia
  American Journal of Kidney Diseases, 1999
• A Study of Biomarkers in Cervical Carcinoma and Clinical Correlation of the Novel Biomarker MN
  Gynecologic Oncology, 1996